{"id":98,"date":"2026-02-12T12:18:21","date_gmt":"2026-02-12T11:18:21","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/?page_id=98"},"modified":"2026-10-21T15:21:36","modified_gmt":"2026-10-21T13:21:36","slug":"26-noviembre","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/programa\/26-noviembre\/","title":{"rendered":"Thursday, 26 November"},"content":{"rendered":"
\r\n\r\n
\r\n
08:00 – 09:30<\/span><\/div>\r\n
SPECIAL SESSION:<\/strong> Thoracic surgery<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. David G\u00f3mez<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n
\r\n Dr. Unai Jim\u00e9nez<\/span>\r\n Hospital Univ. de Cruces, Barakaldo<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:00 – 08:15<\/span><\/div>\r\n
\r\n RESECT & RTT (GECP)<\/span>\r\n
\r\n Dr. Ra\u00fal Emb\u00fan<\/span>\r\n Hospital Univ. Miguel Servet, Zaragoza<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:15 – 08:30<\/span><\/div>\r\n
\r\n Multidisciplinary treatment of thymic tumors<\/span>\r\n
\r\n Dr. Carlos Mart\u00ednez-Barenys<\/span>\r\n Hospital Univ. Germans Trias i Pujol, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:30 – 08:45<\/span><\/div>\r\n
\r\n The utility of synthetic data cohorts in surgical clinical studies of lung cancer<\/span>\r\n
\r\n Dr. Gabriel Barcel\u00f3<\/span>\r\n Hospital Cl\u00ednico San Carlos, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:45 – 09:00<\/span><\/div>\r\n
\r\n Sub-lobar resections after neoadjuvant treatment<\/span>\r\n
\r\n Dr. Luc\u00eda Reyes<\/span>\r\n Hospital Univ. M\u00fatua Terrassa, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
09:00 – 09:15<\/span><\/div>\r\n
\r\n Predictors of pathological response after neoadjuvant chemo-immunotherapy \/ Is surgery avoidable after neoadjuvant chemo-immunotherapy? VALID study (GECP)<\/span>\r\n
\r\n Dr. Mariano Provencio<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
09:15 – 09:30<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
08:00 – 09:30<\/span><\/div>\r\n
SPECIAL SESSION:<\/strong> Translational Research (Newman meeting room)<\/em><\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n \r\n
\r\n TBC<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:00 – 08:15<\/span><\/div>\r\n
\r\n Tumor Resistance after Neoadjuvant Chemoimmunotherapy: Insights from Spatial Transcriptomics Analysis<\/span>\r\n
\r\n Dr. Marta Molina-Alejandre<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:15 – 08:30<\/span><\/div>\r\n
\r\n Metagenomics in Lung Cancer: From Microbiome Profiling to Biomarkers and Therapeutic Opportunities<\/span>\r\n
\r\n Dr. Jos\u00e9 Avenda\u00f1o<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:30 – 08:45<\/span><\/div>\r\n
\r\n cfDNA Methylome Deconvolution: New Opportunities for Liquid Biopsy in Lung Cancer<\/span>\r\n
\r\n Prof. Tommy Kaplan<\/span>\r\n The Hebrew University of Jerusalem (Israel)<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
08:45 – 09:00<\/span><\/div>\r\n
\r\n Tertiary Lymphoid Structures and Disease Progression Following Perioperative Chemoimmunotherapy in NSCLC<\/span>\r\n
\r\n Dr. \u00c1ngeles Gil-Gonz\u00e1lez<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
09:00 – 09:15<\/span><\/div>\r\n
\r\n Beyond TMB and PD-L1: TCR Repertoire Metrics and Clonal Dynamics as Biomarkers in NSCLC<\/span>\r\n
\r\n Dr. Cristina Mart\u00ednez-Toledo<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
09:15 – 09:30<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
09:30 – 09:45<\/span><\/div>\r\n
Welcome<\/strong><\/span><\/div>\r\n <\/div>\r\n\r\n
\r\n
09:45 – 10:45<\/span><\/div>\r\n
SESSION I:<\/strong> Future trends in lung cancer: beyond treatment<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. Mariano Provencio<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n
\r\n Dr. Alberto Ruano<\/span>\r\n Universidad de Santiago de Compostela, A Coru\u00f1a<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
09:45 – 10:00<\/span><\/div>\r\n
\r\n Radiomics in lung cancer: screening and delta radiomic<\/span>\r\n
\r\n Dr. Leonor Cerd\u00e1<\/span>\r\n Hospital Univ. y Polit\u00e9cnico La Fe, Valencia<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
10:00 – 10:15<\/span><\/div>\r\n
\r\n AI-driven digital pathology: correlating histopathology with molecular profiles<\/span>\r\n
\r\n Dr. Esther Conde<\/span>\r\n Hospital Univ. 12 de Octubre, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
10:15 – 10:30<\/span><\/div>\r\n
\r\n The impact of exercise on lung cancer outcomes<\/span>\r\n
\r\n Dr. \u00d3scar Mart\u00ednez<\/span>\r\n The Ricky Rubio Foundation, Badalona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
10:30 – 10:45<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
10:45 – 11:15<\/span><\/div>\r\n
\r\n Coffee break<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
11:15 – 12:25<\/span><\/div>\r\n
SESSION II:<\/strong> Updates GECP studies and other projects<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. Mar\u00eda Guirado<\/span>\r\n Hospital General Univ. de Elche<\/span>\r\n <\/div>\r\n
\r\n Dr. Mar\u00eda \u00c1ngeles Sala<\/span>\r\n Hospital Univ. Basurto, Bilbao<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
11:15 – 11:25<\/span><\/div>\r\n
\r\n GECP studies: early stages NSCLC (Nadim Adjuvant, Arian, Sabine, Caster, Merit, Athenea, Migrant)<\/span>\r\n
\r\n Dr. Silvia Sequero<\/span>\r\n Hospital Univ. Cl\u00ednico San Cecilio, Granada<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
11:25 – 11:35<\/span><\/div>\r\n
\r\n GECP studies: advanced stages NSCLC (CUBIK, Zone-Brain, Nivipi-Brain, Palace)<\/span>\r\n
\r\n Dr. Mar\u00eda Jov\u00e9<\/span>\r\n ICO, Hospital Duran i Reynals, L’Hospitalet de Llobregat, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
11:35 – 11:45<\/span><\/div>\r\n
\r\n GECP studies: other thoracic tumors and pharmacogenomics projects (Dumas, Peers, Merlin, Pel\u00edcano, Real Nadim, Sienna)<\/span>\r\n
\r\n Dr. Hugo Arasanz<\/span>\r\n Hospital Univ. de Navarra<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
11:45 – 11:55<\/span><\/div>\r\n
\r\n GECP registries (RTT, Atlas, Liquid Radon, Eliot, Oncog\u00e9nero)<\/span>\r\n
\r\n Dr. Karla Medina<\/span>\r\n Hospital Univ. Ntra. Sra. de Candelaria, Santa Cruz de Tenerife<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
11:55 – 12:05<\/span><\/div>\r\n
\r\n Consensus on the definition of complete resection of NSCLC<\/span>\r\n
\r\n Dr. Vanessa Ospina<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
12:05 – 12:15<\/span><\/div>\r\n
\r\n SLCG accreditation of excellence for thoracic tumor boards<\/span>\r\n
\r\n Dr. Teresa Mor\u00e1n<\/span>\r\n ICO, Hospital Univ. Germans Trias i Pujol, Badalona, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
12:15 – 12:25<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n<\/div>\r\n\r\n
\r\n\r\n
\r\n
12:25 – 13:25<\/span><\/div>\r\n
SESSION III:<\/strong> Early stages: a changing field in lung cancer<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. Florentino Hernando-Trancho<\/span>\r\n Hospital Cl\u00ednico San Carlos, Madrid<\/span>\r\n <\/div>\r\n
\r\n Dr. Sergio V\u00e1zquez<\/span>\r\n Hospital Univ. Lucus Augusti, Lugo<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
12:25 – 12:40<\/span><\/div>\r\n
\r\n Neoadjuvant vs. perioperative treatment: patient selection criteria<\/span>\r\n
\r\n Dr. Patrick Forde<\/span>\r\n St. James’s Hospital, Dublin (Ireland)<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
12:40 – 12:55<\/span><\/div>\r\n
\r\n Choosing between neoadjuvant and perioperative therapy: who benefits most?<\/span>\r\n
\r\n Dr. Mariano Provencio<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
12:55 – 13:10<\/span><\/div>\r\n
\r\n Present and future of targeted therapies in early stage<\/span>\r\n
\r\n Dr. Rosario Garc\u00eda Campelo<\/span>\r\n Hospital Univ. de A Coru\u00f1a<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
13:10 – 13:25<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
13:25 – 14:55<\/span><\/div>\r\n
\r\n Lunch<\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
13:25 – 14:55<\/span><\/div>\r\n
Lunch Satellite Symposium<\/strong> (J. Maritain meeting room)<\/em>Sponsored by BeOne<\/span><\/span><\/div>\r\n <\/div>\r\n\r\n
\r\n
14:55 – 16:10<\/span><\/div>\r\n
SESSION IV:<\/strong> Locoregional lung cancer: current management and future directions<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. Alfredo S\u00e1nchez<\/span>\r\n Hospital Provincial de Castell\u00f3n<\/span>\r\n <\/div>\r\n
\r\n Dr. Javier Luna<\/span>\r\n Hospital Univ. Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
14:55 – 15:10<\/span><\/div>\r\n
\r\n State of the art in the management of locoregional disease<\/span>\r\n
\r\n Dr. Anna Estival<\/span>\r\n Hospital Univ. Insular de Gran Canaria, Las Palmas<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
15:10 – 15:25<\/span><\/div>\r\n
\r\n The role of SBRT in locoregional disease<\/span>\r\n
\r\n Dr. Suresh Senan<\/span>\r\n Amsterdam University Medical Centers (Netherlands)<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
15:25 – 15:40<\/span><\/div>\r\n
\r\n New strategies beyond the PACIFIC trial<\/span>\r\n
\r\n Dr. Enric Carcereny<\/span>\r\n ICO, Hospital Univ. Germans Trias i Pujol, Badalona, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
15:40 – 15:55<\/span><\/div>\r\n
\r\n Targeted therapies in unresectable NSCLC<\/span>\r\n
\r\n Dr. Huang Yiqing<\/span>\r\n National Cancer Centre Singapore<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
15:55 – 16:10<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
16:10 – 16:25<\/span><\/div>\r\n
\r\n Coffee break<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
16:25 – 17:40<\/span><\/div>\r\n
SESSION V:<\/strong> Hopes and hypes of ctDNA<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. Elo\u00edsa Jantus<\/span>\r\n Hospital General Univ. de Valencia<\/span>\r\n <\/div>\r\n
\r\n Dr. Alejandro Olivares<\/span>\r\n Hospital Univ. de Salamanca<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
16:25 – 16:40<\/span><\/div>\r\n
\r\n Approach to ctDNA techniques<\/span>\r\n
\r\n Dr. Atocha Romero<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
16:40 – 16:55<\/span><\/div>\r\n
\r\n The role of ctDNA in early detection<\/span>\r\n
\r\n Dr. Roberto Serna<\/span>\r\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
16:55 – 17:10<\/span><\/div>\r\n
\r\n ctDNA in advanced NSCLC<\/span>\r\n
\r\n Dr. Manuel Cobo<\/span>\r\n Hospital Regional Univ. de M\u00e1laga<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
17:10 – 17:25<\/span><\/div>\r\n
\r\n ctDNA in targeted therapies<\/span>\r\n
\r\n Dr. Patricia Iranzo<\/span>\r\n Hospital Univ. Vall d’Hebron, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
17:25 – 17:40<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
17:40 – 18:45<\/span><\/div>\r\n
SESSION VI:<\/strong> Immunotherapy in advanced NSCLC<\/span><\/div>\r\n <\/div>\r\n
\r\n
Chairs:<\/span><\/div>\r\n
\r\n
\r\n Dr. Juan Coves<\/span>\r\n Hospital Son Ll\u00e0tzer, Palma de Mallorca<\/span>\r\n <\/div>\r\n
\r\n Dr. M\u00f3nica Anto\u00f1anzas<\/span>\r\n Hospital Cl\u00ednico San Carlos, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
17:40 – 17:55<\/span><\/div>\r\n
\r\n Novel immunotherapy strategies: the emergence of bispecific antibodies<\/span>\r\n
\r\n Dr. \u00d3scar Juan-Vidal<\/span>\r\n Hospital Univ. y Polit\u00e9cnico La Fe, Valencia<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
17:55 – 18:10<\/span><\/div>\r\n
\r\n Predictive factors of response in advanced NSCLC<\/span>\r\n
\r\n Dr. Carlos Aguado<\/span>\r\n Hospital Cl\u00ednico San Carlos, Madrid<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
<\/span><\/div>\r\n
\r\n Debate: the importance of administration timing in oncology<\/span>\r\n <\/div>\r\n <\/div>\r\n
\r\n
18:10 – 18:20<\/span><\/div>\r\n
\r\n Pros<\/span>\r\n
\r\n Dr. Enriqueta Felip<\/span>\r\n Hospital Univ. Vall d’Hebron, Barcelona<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
18:20 – 18:30<\/span><\/div>\r\n
\r\n Cons<\/span>\r\n
\r\n Dr. Bartomeu Massut\u00ed<\/span>\r\n Hospital General Univ. Dr. Balmis, Alicante<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n
\r\n
18:30 – 18:45<\/span><\/div>\r\n
\r\n Discussion<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n
\r\n
18:45 – 19:15<\/span><\/div>\r\n
Satellite Symposium<\/strong> (J. Maritain meeting room)<\/em>Sponsored by Pierre Fabre<\/span><\/span><\/div>\r\n <\/div>\r\n
\r\n
<\/span><\/div>\r\n
\r\n CPNM BRAF V600E: nuevas evidencias, integrando perspectivas<\/span>\r\n <\/div>\r\n <\/div>\r\n\r\n<\/div>","protected":false},"excerpt":{"rendered":"08:00 – 09:30 SPECIAL SESSION: Thoracic surgery Chairs: Dr. David G\u00f3mez Hospital Univ. Puerta de Hierro, Majadahonda, Madrid Dr. Unai Jim\u00e9nez Hospital Univ. de Cruces, Barakaldo 08:00 – 08:15 RESECT & RTT (GECP) Dr. Ra\u00fal Emb\u00fan Hospital Univ. Miguel Servet, Zaragoza 08:15 – 08:30 Multidisciplinary treatment of thymic tumors Dr. Carlos Mart\u00ednez-Barenys Hospital Univ. Germans … Leer m\u00e1s<\/a>","protected":false},"author":2,"featured_media":0,"parent":45,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-internas.php","meta":{"footnotes":""},"class_list":["post-98","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/pages\/98","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/comments?post=98"}],"version-history":[{"count":24,"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/pages\/98\/revisions"}],"predecessor-version":[{"id":267,"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/pages\/98\/revisions\/267"}],"up":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/pages\/45"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/educationalsymposium2026\/wp-json\/wp\/v2\/media?parent=98"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}